Papers

2

Total Citations

10

H-Index

2

About

Fabian Derigs is a clinical researcher specializing in the optimization of prostate cancer diagnostics, with a focus on improving the accuracy and reliability of image-guided biopsy techniques. His work primarily addresses the critical challenge of inter-operator variability in MRI/transrectal ultrasound (TRUS) fusion-targeted prostate biopsies. In his most cited study (2021, 7 citations), Derigs prospectively evaluated semi-robotic software-based fusion biopsies, demonstrating that multiple procedural steps contribute to target deviation and false-negative results, thereby highlighting the need for standardized protocols. He further advanced the field with a matched-pair analysis (2023, 3 citations) comparing systematic prostate biopsy via conventional TRUS guidance versus software-based predefined 3D-guidance, showing that 3D-guidance can enhance sampling precision. These contributions are vital for reducing diagnostic errors and improving cancer detection rates. Derigs’ research has direct clinical implications, offering urologists and radiologists evidence-based strategies to minimize operator-dependent variability. His work is foundational for the ongoing refinement of semi-automated biopsy systems, positioning him as a key voice in the transition toward more reproducible, software-assisted prostate cancer diagnosis.

Research Focus

Key Achievements

2
H-Index
2
Papers
10
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
A prospective study on inter-operator variability in semi-robotic software-based MRI/TRUS-fusion targeted prostate biopsies
7 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Heidelberg University, University Medical Centre Mannheim

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago